Alzheimer’s disease may be leaving a more precise anatomical signature in the brain than scientists once realized. A new study published in Translational Psychiatry investigates regional changes in the fine structure of brain tissue immediately beneath the cerebral cortex, known as the juxtacortical region, and links those changes to patterns of gene expression associated with neurodegeneration. The work, led by J. Zhang, L. Sun, X. Yang and colleagues, offers a combined view of Alzheimer’s biology that connects what can be detected through brain imaging with the molecular programs active inside vulnerable neural tissue.

The juxtacortical zone is a narrow but biologically important interface. It lies directly beneath the cortex, the outer layer responsible for functions including memory, language, perception and decision-making. Although much Alzheimer’s research has focused on cortical thinning, large-scale tissue loss and abnormalities in deeper brain structures, the tissue bordering the cortex may reveal earlier or more regionally specific changes. Its organization includes densely packed axons, dendrites, neurons, glial cells and blood vessels, all of which can be affected as the disease progresses. Subtle disruption in this area could therefore provide clues before dramatic anatomical damage becomes visible.

The study’s central idea is that Alzheimer’s disease does not alter every brain region in the same way. Instead, neurodegeneration follows a complex geography shaped by cellular composition, connectivity, metabolism and genetic vulnerability. By examining regional juxtacortical microstructural changes, the researchers seek to move beyond a simple question of whether tissue has shrunk. Microstructure refers to the organization of brain components at scales smaller than conventional anatomical imaging can directly resolve. Variations in water diffusion, tissue organization and local architecture can serve as indirect markers of changes to axons, membranes, extracellular space and other microscopic features.

This regional perspective matters because the same imaging signal can arise from different biological processes. A change in tissue organization may reflect loss of neuronal connections, damage to myelinated fibers, altered glial activity, inflammation or shifts in the balance of cellular compartments. Imaging alone can reveal where abnormalities are concentrated, but it cannot always explain why they occur. The researchers therefore paired their investigation of juxtacortical structure with gene-expression information, creating a bridge between regional anatomy and molecular biology. That combination can help identify which biological pathways may underlie the imaging patterns seen in Alzheimer’s disease.

Gene expression describes the activity of genes within cells and tissues: which genetic instructions are being read, and at what levels. In the Alzheimer’s brain, these molecular signatures can point toward processes such as synaptic dysfunction, immune activation, impaired energy production, protein handling and cellular stress. Mapping gene-expression patterns onto regions showing microstructural alterations may reveal whether vulnerable areas share particular molecular characteristics. It may also help distinguish tissue changes related directly to neurodegeneration from those associated with aging or general brain atrophy. The result is a more layered portrait of disease, linking microscopic organization to the biological machinery that maintains it.

The findings described by the paper’s title suggest that these two forms of evidence—regional microstructure and gene activity—provide complementary insights into Alzheimer’s pathology. Rather than treating the brain as a uniform organ undergoing gradual damage, the research emphasizes a mosaic of vulnerability. Some areas may show distinctive structural disruption alongside gene-expression profiles associated with neuronal injury or altered support-cell function, while other regions may be relatively resilient. Such differences could help explain why symptoms vary between individuals and why memory, language, attention and other abilities can deteriorate along different trajectories.

The work could also influence how scientists think about biomarkers. A biomarker is a measurable biological feature that helps indicate disease presence, progression or response to treatment. Traditional markers of Alzheimer’s include abnormal amyloid and tau proteins, brain volume loss and changes in metabolism. Juxtacortical microstructural measures, especially when interpreted alongside molecular data, could eventually add regional detail to this toolkit. They might help researchers identify tissue at risk, track the spread of degeneration or evaluate whether an experimental therapy is protecting neural architecture even before clinical improvement becomes obvious.

However, the study should not be interpreted as proof that a single imaging signature can diagnose Alzheimer’s disease or predict an individual’s future with certainty. Microstructural measurements are indirect, and gene-expression data often come from specialized datasets that may not capture every cell type or every stage of disease. Differences in age, disease severity, medication, vascular health and individual brain organization can also influence results. The strength of the approach lies not in one isolated measurement, but in the convergence of regional imaging and molecular evidence. Together, these methods can generate testable hypotheses about how and where neurodegeneration unfolds.

The broader message is that Alzheimer’s research is moving toward increasingly integrated maps of the human brain. The study by Zhang, Sun, Yang and colleagues presents the juxtacortical region as a potentially informative frontier, where microscopic tissue organization and gene regulation intersect. If future research confirms these relationships in larger and more diverse groups, the approach could sharpen disease staging and improve the design of targeted therapies. For now, the findings add weight to a crucial principle in neuroscience: understanding Alzheimer’s requires knowing not only which brain regions are damaged, but also how their cellular architecture and molecular identity make them vulnerable.

Subject of Research: Regional juxtacortical microstructural changes and gene expression in Alzheimer’s disease

Article Title: Regional juxtacortical microstructural changes and gene expression provide insights into neurodegeneration in Alzheimer’s disease

Article References: Zhang, J., Sun, L., Yang, X. et al. “Regional juxtacortical microstructural changes and gene expression provide insights into neurodegeneration in Alzheimer’s disease.” Translational Psychiatry (2026). https://doi.org/10.1038/s41398-026-04292-z

Image Credits: AI Generated

DOI: https://doi.org/10.1038/s41398-026-04292-z

Keywords: Alzheimer’s disease, neurodegeneration, juxtacortical microstructure, gene expression, brain imaging, neuroscience, biomarkers, translational psychiatry

A new study suggests that deep brain stimulation may do more than control movement disorders: it could also help repair social behavior disrupted by pain experienced early in life. In research published in Translational Psychiatry, Wan, Du, Yang and colleagues report that stimulating the brain’s anterior cingulate cortex alleviated social deficits associated with early-life pain. The proposed mechanism is a restoration of the balance between excitatory and inhibitory neural signals, a fundamental process that determines how brain circuits respond, adapt and communicate.

Early-life pain has effects that can extend far beyond the moment of injury or medical treatment. During development, the nervous system is rapidly building connections, refining sensory pathways and establishing the networks that support emotion and social behavior. Excessive or poorly regulated pain signals during this period may alter that process. Instead of remaining confined to pain-processing circuits, these changes can influence stress responses, emotional regulation and the ability to interact with other individuals later in life.

The anterior cingulate cortex, or ACC, is particularly important in this story. Located in the frontal region of the brain, it helps integrate emotional information with attention, motivation and decision-making. It is also involved in processing the unpleasantness of pain and in evaluating social experiences. Because the ACC sits at the intersection of pain, emotion and social behavior, disturbances in its activity could provide a neural explanation for why early-life pain is linked to later difficulties with social interaction.

At the cellular level, the brain depends on a delicate equilibrium between excitation and inhibition. Excitatory neurons generally increase the likelihood that neighboring cells will fire, while inhibitory neurons suppress or constrain that activity. This excitatory/inhibitory, or E/I, balance allows neural circuits to remain flexible without becoming either silent or excessively active. If excitation dominates, networks may become unstable and hypersensitive; if inhibition dominates, communication and behavioral responses may be weakened. The study connects social deficits after early-life pain with disruption of this balance in the ACC.

Deep brain stimulation offers a way to influence such malfunctioning circuits directly. The technique uses electrical pulses delivered through precisely positioned electrodes to modify activity in targeted brain regions. Although DBS is best known clinically for treating Parkinson’s disease, essential tremor and several other neurological conditions, researchers are increasingly investigating whether it can reshape circuits involved in mood, motivation and social behavior. The new findings place the ACC among the brain regions that may be responsive to this approach.

According to the study, stimulation of the ACC improved social abnormalities linked to early-life pain while also normalizing indicators of excitatory and inhibitory signaling. This is important because it suggests that the behavioral improvement was not simply a generalized effect of activating the brain. Instead, the intervention may have acted on a specific circuit-level disturbance. By bringing opposing neural forces back toward equilibrium, DBS could make the ACC more capable of processing social information and generating appropriate responses.

The result also highlights a shift in how scientists understand the consequences of pain during development. Pain is often treated as a temporary sensory event, but developing neural systems can interpret repeated or intense pain as an organizing signal. That signal may alter synaptic strength, neuronal excitability and communication between brain regions. Over time, these changes could become embedded in circuits that regulate social engagement. The study’s emphasis on E/I balance suggests that developmental pain may produce lasting behavioral effects through measurable changes in network physiology rather than through an unexplained psychological process.

The findings are likely to attract attention because social deficits are difficult to treat and can appear across many neurological and psychiatric conditions. However, DBS is an invasive therapy involving neurosurgical implantation, and the study does not mean that the treatment is ready for routine use in people affected by early-life pain. Translating a circuit-level discovery into a safe human therapy requires extensive work, including confirmation in independent models, determination of the most effective stimulation parameters and careful assessment of possible side effects. The ACC is involved in many functions, so altering its activity could influence emotion, attention or pain perception in unwanted ways.

Even with those limitations, the research offers a potentially powerful framework for future therapies. If social difficulties can be linked to a specific imbalance between excitation and inhibition, treatments might eventually be designed to correct that imbalance with greater precision. DBS is only one possibility. Noninvasive stimulation, pharmacological treatments that selectively influence inhibitory or excitatory signaling, and therapies combining behavioral training with neuromodulation could also emerge from the same biological insight.

The study’s central message is that the developing brain may retain a capacity for repair, even after early adverse experiences have changed its circuitry. By targeting the ACC and restoring the neural balance that supports its function, deep brain stimulation improved social behavior in the reported research. The work does not erase the complexity of developmental pain, but it identifies a concrete biological pathway connecting early injury, altered brain networks and later social difficulties. That connection could help move the field closer to treatments that address not only pain itself, but also the long-term social consequences it can leave behind.

Subject of Research: Deep brain stimulation, early-life pain, social deficits, and excitatory/inhibitory balance in the anterior cingulate cortex

Article Title: Deep brain stimulation ameliorates social deficits from early-life pain by restoring excitatory/inhibitory balance in the anterior cingulate cortex

Article References: Wan, X., Du, T., Yang, D. et al. Deep brain stimulation ameliorates social deficits from early-life pain by restoring excitatory/inhibitory balance in the anterior cingulate cortex. Transl Psychiatry (2026). https://doi.org/10.1038/s41398-026-04311-z

Image Credits: AI Generated

DOI: https://doi.org/10.1038/s41398-026-04311-z

Keywords: deep brain stimulation, early-life pain, social deficits, anterior cingulate cortex, excitatory/inhibitory balance, neuroscience, brain stimulation, developmental pain, social behavior